Syndax Pharmaceuticals (SNDX) Interest & Investment Income: 2015-2024
Historic Interest & Investment Income for Syndax Pharmaceuticals (SNDX) over the last 10 years, with Dec 2024 value amounting to $26.1 million.
- Syndax Pharmaceuticals' Interest & Investment Income rose 72.39% to $462,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $1.4 million, marking a year-over-year increase of 48.74%. This contributed to the annual value of $26.1 million for FY2024, which is 23.28% up from last year.
- According to the latest figures from FY2024, Syndax Pharmaceuticals' Interest & Investment Income is $26.1 million, which was up 23.28% from $21.2 million recorded in FY2023.
- In the past 5 years, Syndax Pharmaceuticals' Interest & Investment Income registered a high of $26.1 million during FY2024, and its lowest value of $403,000 during FY2021.
- In the last 3 years, Syndax Pharmaceuticals' Interest & Investment Income had a median value of $21.2 million in 2023 and averaged $17.7 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 52.08% in 2021, then spiked by 1,357.07% in 2022.
- Over the past 5 years, Syndax Pharmaceuticals' Interest & Investment Income (Yearly) stood at $841,000 in 2020, then tumbled by 52.08% to $403,000 in 2021, then soared by 1,357.07% to $5.9 million in 2022, then spiked by 260.41% to $21.2 million in 2023, then increased by 23.28% to $26.1 million in 2024.